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CHARACTERISTICS OF EXCITATORY SYNAPSES AND MUTANT 
HUNTINGTIN DISTRIBUTION IN THE Q175 MOUSE MODEL OF 
HUNTINGTON’S DISEASE 
DICKSON TIK SANG CHEN 
ABSTRACT 
Huntington’s disease is an inherited neurodegenerative disease characterized by the 
degeneration of the cerebral cortex, thalamus, and striatum. The loss of neurons in the 
cerebral cortex and the thalamus may affect the synaptic circuitry in the striatum as these 
regions send glutamatergic projections (corticospinal & thalamostriatal) to neurons in the 
striatum. Prior studies have suggested the detrimental impact that the mutant Huntingtin 
protein (mHTT) may have on corticostriatal afferents, but less is known thalamic inputs to 
the dorsal striatum. In this study, we report a 50% reduction in thalamostriatal axospinous 
synapse density and significant reductions in dendritic spine volume at the ultrastructural 
level using electron microscopy. Additionally, dystrophic alterations to mitochondria size 
and morphology were also found. At the microcircuit level, we report a reduction in the 
spatial abundance of thalamostriatal axon terminals at the rostral, middle, and caudal levels 
of the dorsolateral striatum while an inverse distribution was observed for mHTT, 
suggesting a novel topographic distribution of thalamostriatal projections and mHTT along 
the rostral-caudal axis of the dorsolateral striatum. These findings are novel in the Q175+/-
HD mouse model and supports the theory of an excitatory: inhibitory imbalance 
contributing to structural synaptic changes in the dorsal striatum. Further studies of the 
corticostriatal projections will determine the global extent of this imbalance. 
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INTRODUCTION 
Background & Prevalence of Huntington’s Disease (HD) 
In today’s era of medical mysteries, neurodegenerative diseases have risen to the 
forefront of modern scientific investigation and research. As one of many disorders that 
have no known cure, Huntington’s disease (HD) stands out as a notable genetic 
neurodegenerative disease with debilitating symptoms. HD is a hyperkinetic movement 
disorder that leads to the progressive deterioration of motor, cognitive, and psychiatric 
faculties (Harper & Jones, 2002). A distinct hallmark of HD is the early prevalence of 
choreiform movement, a motor dysfunction characterized as uncontrollable dance-like 
movements (NINDS, 1998), and subsequently other motor deficits such as rigidity and 
impaired coordination. Cognitive deficits such as inability to multitask and perform 
executive function tasks (Papoutsi, Labuschagne, Tabrizi, & Stout, 2014), have also been 
reported. Onset of HD has been shown to result in the progressive manifestation of 
neuropsychiatric symptoms such as apathy, irritability, and depression (Craufurd et al., 
2001). 
Around 5.70 per 100,000 people are affected by HD in North America, Europe, and 
Australia (Pringsheim et al., 2012), with a prevalence of 6.52 per 100,000 people in the 
United States (Bruzelius et al., 2019) alone. Those with HD develop symptoms that 
progressively impact activities of daily living. After initial diagnosis, adult HD patients on 
average typically live for an additional 10-20 years. In less than 10% of reported HD cases, 
a juvenile form of the disease (JHD) affects children and adolescents (Huntington’s 
Disease Society of America) with typically adult-onset symptoms manifesting prior to 
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adulthood. The life expectancy of children with this phenotype is notably shorter. Both 
forms of HD have no cure and limited treatment options, emphasizing the importance of 
conducting scientific and clinical research to prolong life and improve the quality of life of 
HD patients. 
Etiology & Pathology of HD 
HD is an autosomal dominant inherited disease. Patients with HD carry a mutated 
heterozygous copy of huntingtin (one normal allele, one mutated allele), a gene that 
encodes the production of the huntingtin protein (HTT). The mutation, which can be traced 
to the 4p16.3 gene, is characterized by the unstable expansion of glutamine (CAG) 
trinucleotide repeats within exon 1 (HDCRG, 1993). The normal huntingtin gene (HTT) 
contains 6-34 CAG repeats. In patients with HD, HTT contains a polyglutamine (polyQ) 
sequence attached to the NH2 terminal that exceeds 35 repeats (HDCRG, 1993). The length 
of the expanded HTT polyQ sequence has previously been shown to result in abnormal 
splicing of HTT mRNA (Sathasivam et al., 2013) and alterations to normal post-
translational modifications involved with HTT cleavage (Graham et al., 2006). Prior 
research also shows an inverse correlation between the length of the polyQ expansion and 
age of onset when HD symptoms are first reported – longer CAG repeat expansion 
sequences were found to contribute to the manifestation of HD pathology at earlier ages. 
(Andrew et al., 1993; Swami et al., 2009). Together, these results implicate polyQ sequence 
length as the basis for HD, influencing phenotypic severity and producing a mutant form 
of the huntingtin protein (mHTT). 
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The production of misfolded fragmented mHTT proteins leads to protein 
aggregation in specific brain regions. Studies in transgenic HD model mice and in human 
HD brains show that mHTT aggregates appear mainly in the cerebral cortex and the 
striatum, localizing in striatal nuclei after the misfolded protein oligomerize and form 
inclusions, as well within dystrophic neurites and the cytoplasm (Davies et al., 1997; 
DiFligia et al., 1997; Gutekunst et al., 1999). Though the role of normal HTT is not fully 
understood, it is believed that the protein has regulatory functions in a variety of critical 
cellular processes such as gene transcription, vesicular transport, brain-derived 
neurotrophic factor (BDNF) production, normal synaptic functioning, neurodevelopment, 
and neuronal axonal transport (Cattaneo, Zuccato, & Tartari, 2005; Sugars & Rubinsztein, 
2003; Zuccato & Cattaneo, 2014; Trushina et al., 2004). The production of mHTT and the 
formation of inclusion bodies impairs these vital cellular processes. Due to limited 
research, the molecular mechanisms by which mHTT disrupts these processes are unclear. 
Some studies suggest that mHTT aggregates alter transcriptional regulators responsible for 
neuronal survival (Jiang et al., 2003) and players responsible for the maintenance of the 
proteosome network (Bence et al., 2011).  
The Degenerating HD Brain 
 It remains a topic of controversy whether the formation of inclusion bodies is an 
autonomous toxic cell response, or whether it is a non-cell autonomous neuroprotective 
response to neuronal dysfunction and degeneration. However, one thing remains clear – 
the formation and aggregation of mHTT is a precursor event that leads to the pathogenesis 
of HD. With the progression of the disease, HD symptoms continue to worsen, and the loss 
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of synaptic connections are observed. Morphological studies reveal significant atrophy of 
neurons in HD, most notably in the striatum, but also in the neocortex and subcortical 
structures like the thalamus (Vonsattel & DiFiglia, 1998). These brain regions, more 
predominantly the cerebral cortex and the striatum, are the focus of extensive research to 
investigate mechanisms that contribute to region-specific degeneration. In a side-by-side 
comparison of coronal brain sections, drastic changes in size and structure can be seen 
between the normal and HD human brain (Fig. 1). In the HD brain (left), a large reduction 
in the cerebral cortex and the caudate nuclei of the basal ganglia can be seen in addition to 
enlargement of the lateral ventricles (Fig. 1). On T1 and T2 MRI images, atrophy of the 
caudate nuclei is evident with enlargement of the frontal horns of the lateral ventricles in 
the HD brain (Fig. 2). Other early studies demonstrate that the caudate and putamen nuclei 
are highly susceptible to degeneration. One postmortem study demonstrated a 57% 
reduction of caudate cross-sectional area and a 64% reduction of putamen cross-sectional 
area in HD brains (grades 0 – 4 on a clinical HD severity scale) when compared to controls 
(Monte, Vonsattel, & Richardson, 1998). To fully grasp the magnitude of these changes in 
the brain, an understanding of the function, motor pathways, inputs and outputs of basal 
ganglia structures is necessary. 
 
Figure 1: Coronal slices from normal & HD human brain. Coronal slice of the 
telencephalon of an advanced HD brain (grade 4) (LEFT). Coronal slice of the 
telencephalon of a normal brain (RIGHT). Red arrow indicates expansion of the 
lateral ventricles. Green arrows denote reduction in cerebral cortex volume. The 
blue arrow shows the reduction in caudate size. Figure adapted from Reiner, 2011. 
Image courtesy of the Harvard Brain Tissue Research Center. Abbreviations: C, 
caudate; GP, globus pallidus; P, putamen; IC, internal capsule
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Figure 2: Axial T1/T2 weighted MRI scans from normal & HD human brain. T1 
(a)and T2-weighted (b) scans of a middle-aged HD brain at the level of the basal 
ganglia (TOP). T1 (a) and T2-weighted (b) scans of a normal brain at the level of 
the basal ganglia (BOTTOM). Figure adapted from Negi et al., 2014. Abbrevia-
tions: 1, head of caudate nucleus; 2, putamen
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Function & Role of the Basal Ganglia 
 The basal ganglia is a structure made of a cluster of subcortical structures that 
consist of the dorsal striatum (caudate and putamen), ventral striatum (nucleus accumbens, 
or NA), globus pallidus (GPi and GPe), ventral palladium, substantia nigra (SNc and SNr) 
and the subthalamic nucleus (STN) (Fix, 2008). Collectively, the striatum is involved with 
the coordination of cognitive tasks, such as action selection and reinforcement learning 
(Stocco et al., 2010), as well as emotional processing tasks which are facilitated by close 
anatomical associations with structures of the limbic system. The dorsal striatum 
specifically is primarily involved with the regulation of voluntary motor control. 
Collectively, neurons in the caudate and putamen process reward and sensory inputs, 
relaying the appropriate motor commands to the decision-making cortices to ensure 
adequate time is given in preparation for a planned motor movement (Chakravarthy, 
Joseph, & Bapi, 2010). This feedforward and feedback mechanism ensures that movement 
is smooth and fluid. Thus, the striatum plays an important role as the “integrator,” 
processing afferent information and regulating voluntary motor movements. 
Striatal Medium-sized Spiny Neuron (MSN) Subtypes  
The striatum contains specialized medium-sized spiny neurons (MSNs) which 
make up the majority of all neurons. MSNs are projection neurons that secrete the 
inhibitory neurotransmitter 𝛾-aminobutyric acid (GABA), and they process afferent 
information and relay feedback to other basal ganglia structures to initiate, facilitate, and 
execute motor movement. MSNs receive excitatory afferents from the cerebral cortex and 
the thalamus and relay information to other basal ganglia structures via parallel motor 
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circuits called the direct and indirect pathways. Appropriate efferent information is then 
relayed to the motor cortices to modulate motor activity. Within the motor pathways, MSNs 
can be divided into two subtypes based on the expression of dopamine (DA) receptors: 
striatonigral MSNs that express D1 receptors (D1 MSNs), and striatopallidal MSNs that 
express D2 receptors (D2 MSNs) (Gerfen et al., 1990). Together, these two subclasses of 
MSNs make up approximately 90-95% of all neurons in the striatum (Graveland & 
Difiglia, 1985). 
The SNc, which releases DA, sends afferent projections to MSNs. DA modulates 
the activation of the direct and indirect pathways by acting differentially on the DA 
receptors of D1 and D2 MSNs, activating D1 receptors and inhibiting D2 receptors (Gerfen 
& Surmeier, 2011) (Fig. 3). While both D1 and D2 MSNs secrete GABA and are modulated 
by DA, they express different neuropeptides, namely D1 MSNs express substance P (SP), 
while D2 MSNs express enkephalin (ENK) (Gerfen et al., 1990). Both SP and ENK serve 
neuroregulatory roles, modulating the release of excitatory transmitter glutamate and 
ensuring neurons are not overactivated (Blomeley, Kehoe, & Bracci, 2009; Steiner & 
Gerfen, 1998). DA has also been reported to differentially regulate the expression of the 
neuropeptides in the respective MSN subtypes (Gerfen, Mcginty, & Young, 1991).  
Figure 3: Dopamine acts differentially on D1 & D2 receptors on MSNs. The 
direct and indirect pathways process information from the cortex. DA from SNc 
modulates the activation of these pathways by differentially acting on D1 and D2 
receptors of MSNs in the striatum. Figure adapted from BioRender, 2020. Abbrevi-
ations: GPe, external segment of the globus pallidus; GPi, internal segment of the 
globus pallidus; SNc, substantia nigra pars compacta; STN, subthalamic nucleus
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Direct & Indirect Pathways of the Basal Ganglia 
 The direct and indirect motor pathways of the basal ganglia play important roles in 
the modulation of motor activity. Generally, MSNs from each respective pathway receive 
extrinsic glutamatergic projections from the cerebral cortex and the thalamus as well as 
intrinsic dopaminergic projections from the SNc (Gerfen & Surmeier, 2011). The 
glutamatergic projections are relayed to different basal ganglia structures based on the 
MSN subtype, differentially modulating the activity of the MSNs in each pathway. The 
final basal ganglia output structures send efferent projections to thalamic and brainstem 
nuclei to modulate the activity of motor neurons. The structures and neurotransmitters of 
each pathway are summarized in Figure 4.  
In the direct pathway, excitatory glutamatergic inputs from the cerebral cortex and the 
thalamus activate GABAergic D1 MSNs in the striatum. Neurons in the SNc secrete DA, 
which binds to D1 receptors, further activating D1 MSNs. Excitation of MSNs increases 
the secretion of GABA, causing a strong inhibitory effect on GPi neurons, which are also 
inhibitory in nature. Consequently, the GPi neurons secrete less GABA to the ventral 
anterior and ventral lateral (VA/VL) thalamic nuclei, providing a net reduction of inhibition 
to VA/VL within this pathway. Since the VA/VL nuclei are glutamatergic, this 
disinhibition from the GPi neurons allow the VA/VL nuclei to project more excitatory 
inputs to the frontal and premotor cortices, providing an overall net excitatory effect. As a 
result, the direct pathway is termed the “facilitatory” pathway, as components of this 
pathway collectively work to facilitate, initiate, and execute motor activity. The indirect 
pathway serves to balance the direct pathway, as the components of this pathway work to 
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inhibit motor activity overall. In this pathway, excitatory glutamatergic inputs from the 
cerebral cortex and thalamus activate GABAergic D2 MSNs in the striatum. Neurons in 
the SNc secrete DA, which binds to D2 receptors. However, instead of providing an 
excitatory effect as seen in the direct pathway, DA serves a different role, inhibiting D2 
MSN activation and dampening excitation. As a result, D2 MSNs secrete less GABA and 
provide weaker inhibition of neurons in the GPe which are also inhibitory in nature. 
Consequently, GPe neurons secrete more GABA to the STN, causing the STN to project 
more excitatory glutamatergic inputs to GPi neurons. This is where the indirect pathway 
converges with the direct pathway. Due to increased excitation from the STN, the 
inhibitory GPi neurons then secrete increased levels of GABA onto the VA/VL thalamic 
nuclei, causing VA/VL to project less excitatory inputs to the frontal and premotor cortices, 
producing an overall net inhibitory effect. As a result, the indirect pathway is termed the 
“inhibitory” pathway, as the components of this pathway work to limit motor activity.  
 
Figure 4: The direct and indirect motor pathways of the basal ganglia. MSNs 
receive excitatory afferents from numerous cortical areas (M1, PMC, SMA, CMA), 
the thalamus (CM) and the SNc from within the basal ganglia. Efferent outputs from 
the GPi and SNr are projected onto thalamic (VA/VL) and brainstem nuclei (PPN) 
to modulate motor neuron activity in the brain stem/spinal cord and the motor cor-
tex. Black arrows indicate inhibitory projections. Gray arrows indicate excitatory 
projections. Figure adapted from Galvan, 2014. Abbreviations: CM, centromedian 
nucleus of the thalamus; CMA, cingulate motor area; Dir., direct pathway; GPe, 
globus pallidus, external segment; GPi, globus pallidus, internal segment; Indir., 
indirect pathway; M1, primary motor cortex; PMC, pre-motor cortex; PPN, pedun-
culopontine nucleus; SMA, supplementary motor area; SNc, substantia nigra pars 




Knowledge of the parallel motor pathways reiterate the opposing, yet important 
roles of D1 and D2 MSNs in modulating motor activity. In line with findings of 
degenerating MSNs in the caudate and putamen of HD patients, an imaging study 
examining dopamine receptor binding demonstrates that both D1 and D2 dopamine 
receptors in the caudate and putamen are lost as well in symptomatic and asymptomatic 
HD patients (Weeks et al., 1996). In the scope of the indirect pathway, the atrophy of D2 
MSNs results in less inhibitory projections to the GPe. Consequently, GPe neurons would 
have a larger inhibitory control over the STN with the secretion of more GABA onto 
neurons in the GPi. This leads to an overall disinhibition of the thalamus as GPi neurons 
secrete less GABA onto the thalamic nuclei, contributing to increased thalamic excitation. 
Overall, the loss of MSNs in HD generates a net excitatory effect in the indirect pathway. 
Transgenic HD Mouse Models 
 The degeneration of MSNs within the striatum highlights the importance of 
developing effective models to study HD. Over time, transgenic mouse models have been 
developed and refined to study the neuropathological, functional, and morphological 
changes that mimic those seen during HD progression. Using mouse models to study HD 
provides benefits as these tools allow for visual and quantitiatve assessments of changes to 
vulnerable brain regions such as the striatum and cerebral cortex during stages of 
progression. While all models have contributed to novel discoveries, each HD model varies 
based on its genetic makeup and the way they were genetically engineered. The first widely 
used transgenic models for studying HD were the R6/1 and R6/2 mouse models. These 
models are fragment models and created by introducing a plasmid that contain a small N-
 14 
terminus fragment of the mutant human HD gene, including the promoter sequences, exon 
1, and the polyQ sequence. R6/1 and R6/2 mice contain polyQ sequences with 116 and 144 
CAG repeats respectively (Mangiarini et al., 1996). Though the R6/2 mouse model has 
been widely used in behavioral studies, due to the way the plasmid was genetically 
introduced, the length of polyQ repeats is unstable and may vary within the germ and 
somatic lines (Bates, 1997). Another study found that R6/2 mice with 110 and 160 polyQ 
repeats had a greater density of mHTT inclusions and aggregates at earlier ages compared 
to mice with 210 and 310 polyQ repeats (Cummings et al., 2012). This finding contradicts 
the relationship observed in humans where longer polyQ lengths are associated with earlier 
disease severity (HDCRG, 1993). Together, these findings suggest that the R6/2 model 
may not be the best model to study the time-sensitive neuropathological changes observed 
in human HD progression.  
 Unlike R6/1 and R6/2 fragment models, full length mouse models such as YAC128 
and BACHD mice are genetically engineered using a full-length copy of the mutant gene. 
To generate YAC128 mice, plasmids containing multiple full-length copies of mutant 
human HTT (116 CAG and 9 CAA polyQ repeats) are introduced into mice via a yeast 
artificial chromosome while BACHD mice are formed by the introduction of a plasmid 
containing full-length copies of the mutated human HTT (97 CAG-CAA polyQ repeats) 
via a bacterial artificial chromosome (Pouladi et al., 2012; Gray et al., 2008). Though no 
evidence of somatic instability has been reported in these full-length models, a study 
showed differences between the mouse models where accumulation and spread of mHTT 
aggregates was present in the YAC128, but absent in the BACHD model (Pouladi et al., 
 15 
2012). The same study also found decreased mRNA gene expression in the striatum for the 
YAC128 model, but no changes to the BACHD model. These differences could be 
attributed to the presence of a mixed glutamine polyQ sequence (CAG and CAA) instead 
of a pure CAG sequence (Pouladi et al., 2012). These findings suggest that using YAC128 
or BACHD mice for mHTT histological studies may not be ideal as the mixed CAG-CAA 
polyQ repeats may serve as a confounding factor. Additionally, what is observed from 
these histological studies may not be an accurate representation of what is happening in the 
human HD brain since pathophysiology is caused by pure CAG polyQ expansion of HTT, 
not mixed. 
Of all rodent models, knock-in models are by far the most realistic rodent models 
of human HD are. Unlike the fragment and full-length models which introduce a foreign 
plasmid into the mouse genome, knock-in mice are generated using mouse embryonic stem 
cells with a pre-determined polyQ repeat length. By using homologous recombination, a 
chimeric mouse-human exon 1 with pure CAG polyQ repeats can be created within the 
native full-length mouse HTT locus, preventing issues of somatic instability. Additionally, 
these transgenic mice are heterozygous, with one normal allele and one mutated HTT allele, 
mirroring the genetic etiology seen in HD patients. The two commonly used knock-in 
models are the CAG140 (referred to as Q140) and the zQ175 (referred to as Q175+/-) mice 
which contain 140 and 188 CAG polyQ repeats within their HTT gene respectively 
(Menalled et al., 2012). Aside from the longer polyQ length, the Q175+/- model is identical 
in genetic construction to the Q140 mouse model. Based on motor assessments and 
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neuropathological findings, both models are useful to studying mechanisms underlying 
neuronal dysfunction (Menalled, Sison, Dragatsis, Zeitlin, & Chesselet, 2003; Menalled et 
al., 2012). Of all discussed transgenic rodent models, the Q140 and Q175+/- mouse models 
offer the best construct validity and may be the most accurate way to replicate human HD 
pathology in mice. 
Structural Alterations to MSNs in HD 
As discussed, striatal MSNs receive extrinsic glutamatergic afferents from the 
cerebral cortex and the thalamus in addition to intrinsic dopaminergic afferents from the 
SNc which modulate the activity of the direct and indirect pathways. The significant loss 
of MSNs during the course of HD has prompted an in-depth examination of dopaminergic 
projections to determine the subsequent changes to DA neuromodulation in the direct and 
indirect pathways. Studies of D1 and D2 MSNs in HD patients shows a pattern of time-
dependent degeneration, characterized by the loss of D2 (ENK) receptors during early 
stages of the disease (grade 0), followed by the sequential loss of D1 (SP) receptors in all 
other stages (grade 2, 3) of disease progression (Glass, Dragunow, & Faull, 2000). 
Similarly, immunohistochemical studies on human HD tissue demonstrate loss of ENK+ 
D2 MSNs early on (grade 0), followed by reduction (grade 1+) of SP+ D1 MSNs at a later 
stage of disease progression (Deng et al., 2004). These findings suggest that indirect 
pathway MSNs are more susceptible to degeneration at earlier timepoints than direct 
pathway MSNs.  
The combination of findings in these studies support a pattern of selective neuronal 
vulnerability to degeneration based on the stage of HD progression, characterized by high 
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initial vulnerability of D2 MSNs during earlier stages, followed by a gradual reduction in 
D1 MSNs with disease progression. These observations mirror the chronology of HD 
symptoms, as HD patients develop involuntary choreiform movements early on in the 
trajectory of the disease, followed by the loss of ability to control voluntary movements, 
resulting in motor deficits such as incoordination and bradykinesia (Bates et al., 2014). 
Initial choreiform symptoms may be attributed to the early susceptibility of D2 MSNs to 
degeneration, while loss of voluntary motor control can be due to further degeneration of 
both D2 MSNs and D1 MSNs at later stages. These early findings suggest that MSN loss 
may result in differential changes to striatal microcircuitry. 
Elucidating the specific mechanisms responsible for alterations to synaptic 
connections in the striatum requires in-depth characterization of the structural properties 
of MSNs. In four different studies, quantifications of dendritic spine density paint a clear 
picture of the structural changes to MSNs. Studies in symptomatic (3-month-old) R6/2 
mice demonstrate reduced dendritic spine density on MSNs (Klapstein et al., 2001). In 
aged (18–23-month-old) BACHD mice, a 35% reduction in dendritic spine density on 
MSNs was observed (Rocher et al., 2016). At 7 and 12 months, both homozygous and 
heterozygous Q175 mice also show reduced dendritic spine density on MSNs 
(Indersmitten, Tran, Cepeda, & Levine, 2015). While these studies are in clear agreement 
of degenerative changes to dendritic spines at the symptomatic stage, it is unclear whether 
these observations are observed among D1 and D2 MSNs. From our lab, a recent study 
found that the density of D1 dendritic spines on MSNs was significantly decreased at 12 
months in heterozygous Q175+/- mice while no changes were observed for D2 spine density 
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(Goodliffe et al., 2018). All studies demonstrate that there are post-synaptic structural 
changes to MSNs in the HD models. Electrophysiological assessments in the same studies 
also demonstrate functional physiological changes to MSNs. Collectively, these studies 
suggest that the presence of mHTT acts on dendritic spines, leading to altered synaptic 
transmission. 
Corticostriatal & Thalamostriatal Inputs to MSNs 
While the activity of striatal MSNs is modulated by DA via D1 and D2 receptors, 
they receive glutamatergic corticostriatal inputs from the cerebral cortex and 
thalamostriatal inputs from the thalamus. As discussed, while the striatum undergoes the 
most extensive degeneration, the cerebral cortex and thalamus also undergo atrophy. These 
observations suggest that the loss of synaptic connections between cortical and thalamic 
neurons onto MSNs may also contribute to altered synaptic transmission. Studying the 
synaptic mechanisms of glutamatergic projections to the striatum requires in-depth 
characterization of the structural properties of MSNs receiving these projections. 
Fortunately, the axon terminals of MSNs receiving cortical and thalamic inputs can be 
labelled based on the expression of two subtypes of vesicular glutamate transporter to 
package glutamate into synaptic vesicles: excitatory cortical neuron axon terminals express 
vesicular glutamate transporter 1 (VGLUT1) and excitatory sub-cortical neuron axon 
terminals express vesicular glutamate transporter 2 (VGLUT2) (Femeau et al., 2001; 
Herzog et al., 2001; Fujiyama et al., 2004). Hence, the differential expression of transporter 
type allows corticostriatal and thalamostriatal inputs to be labelled with VGLUT1 and 
VGLUT2 respectively.  
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Although specific labelling of axon terminals allows for the characterization of 
structural changes to cortical and thalamic inputs to the striatum, ultrastructural studies are 
limited as they are labor and time intensive. An ultrastructural study of the glutamatergic 
inputs in the striatum of Q140 knock-in model reveals a 15-20% reduction in VGLUT1+ 
axon terminals (VGLUT1+ synapses) and VGLUT2+ axon terminals (VGLUT2+ 
synapses) in the striatum at 12-months (Deng et al., 2013). A follow up study from the 
same group reveals that the spatial abundance of VGLUT1+ and VGLUT2+ synapses onto 
D1 spines were reduced by 63.3% and 38.1% respectively at 12-months (Deng et al., 2014). 
A similar study in R6/2 mice (~2 to 3 months old) demonstrate a reduction in the density 
of excitatory axospinous synapses onto D1 and D2 spines (Parievsky et al., 2017). 
However, only a significant reduction among VGLUT1+ synapses was reported. In 
addition to assessments of spine density in the Q175+/- mouse, confocal imaging studies 
from our lab demonstrated no changes to the density of VGLUT1+ and VGLUT2+ 
particles found at both axodendritic and axospinous terminals in the dorsolateral striatum 
compared to wildtype mice (Goodliffe et al., 2018). The differing results from these studies 
highlights the need for additional ultrastructural studies of corticostriatal and 
thalamostriatal synapses in the striatum as mechanisms at the neuronal level can provide 
insights to the way that the presence of mHTT may be affecting glutamate 
neurotransmission. These alterations would affect neighboring MSNs as well, suggesting 




Abnormal Mitochondria Function & Morphology in HD  
While confocal studies give insight to how the presence of mHTT may affect the 
larger projections to MSNs, mHTT may have a greater impact at a smaller ultrastructural 
scale that may not be observed at the microcircuit level. Ultrastructural studies provide the 
unique opportunity to evaluate the effect of mHTT presence on organelles such as 
mitochondria within pre-synaptic axon terminals arising from cortical and thalamic inputs. 
Studies of the normal HTT protein demonstrates its importance in the trafficking of 
mitochondria in neurons via binding to the HAP1 protein (Trushina et al., 2004). In the 
context of HD, mHTT has been found to have a higher affinity for synaptic vesicles in R6/1 
and R6/2 mice, decreasing the association of HAP1 with synaptic vesicles and as well as 
glutamate release via synaptic vesicles (Li et al., 2003). This finding provides evidence of 
the effect of mHTT on mitochondria and its secondary effect on synaptic transmission. 
Morphological studies of mitochondria in cellular HD mouse models show evidence of 
mitochondrial fission, fragmentation, and disorganized dilated cristae, in addition to 
reduced volume (Costa et al., 2010; Song et al., 2011). Studies in moderate-to-severe grade 
HD patients also demonstrate a grade-dependent decline in the number of mitochondria 
found in MSNs (Kim et al., 2010). 
Purpose of the Current Study 
The structural changes to synapses with thalamostriatal (VGLUT2+) labelled axon 
terminals has been understudied in the field of HD. Prior studies examining the structure 
of VGLUT2+ synapses have yielded conflicting results at the ultrastructural and 
microcircuit levels. The main goal of the current study seeks to investigate the effects of 
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mHTT on VGLUT2+ synapses in the knock-in Q175+/- mouse model compared to 
wildtype. The first part of this study characterizes the ultrastructural features of 
thalamostriatal (VGLUT2+) and non-thalamostriatal (VGLUT2-) axospinous excitatory 
synapses in the neuropil of the dorsal striatum using serial block-face scanning electron 
microscopy (EM) and 3D reconstruction techniques. Examination of synapse density, 
characteristics, mitochondria morphology, and distribution of synapse size will reveal 
insights into synaptic functioning with presence of mHTT at the single neuron level. 
The second part of this study examines the density, distribution and colocalization 
of mHTT at immunolabeled VGLUT2+ axon terminals at three levels of resolution in the 
striatum along the rostral-caudal axis using a combination of immunofluorescent 
techniques, confocal light microscopy and particle and colocalization analyses. These 
studies will reveal the extent to which mHTT influences excitatory inputs to the striatum 
at the neuron population level. Together, the results of this study will describe the mHTT-
derived changes that occur in the dorsolateral striatum at multiple levels in an important 
and widely used mouse model of HD. At the ultrastructural level, we expect to see 
differences in synapse characteristics, size, and mitochondria morphology between 
genotype and VGLUT2+/- groups. At the microcircuit level, we expect to see differences 




 To examine the ultrastructural features of excitatory axospinous synapses in the 
dorsal striatal neuropil, the commonly studied Q175+/- mouse model of HD was selected 
for the electron microscopy (EM) studies. A total of five one-year old male mice (n = 2 
wildtype, n = 3 Q175+/-) were used. To examine the density, distribution and colocalization 
of VGLUT2 and mHTT immunolabeled particles in the dorsolateral striatum, a total of six 
one-year old male mice (n = 3 wildtype, n = 3 Q175+/-) were used. All mice used were 
obtained from the CHDI Foundation (CHDI-81008006) and were individually housed at 
Boston University School of Medicine (Boston, MA) at the Laboratory Animal Science 
Center and kept under a 12 h light/dark cycle. The Boston University School of Medicine 
is fully accredited by the Association for Assessment and Accreditation of Laboratory 
Animal Care (AAALAC). All animal care and experimentation were done with accordance 
to guidelines provided by the Guide for the Care and Use of Laboratory Animals (NIH, 
2011) and the US Public Health Service Policy on Humane Care and Use of Laboratory 
Animals (OLAW, 2015). 
 
Electron Microscopy Studies of Excitatory Axospinous Synapses 
 
Perfusion & Tissue Harvesting 
 Mice were anesthetized with an intraperitoneal injection of sodium pentobarbital 
for thoracotomy, as described (LeBlang et al., 2020). Briefly, a Socumb Solution (6 g 
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Sodium Pentobarbital/250mL, Henry Schein) with a 1:5 dilution factor in sterile saline was 
delivered at 15 µL/2 g body weight. Animals were then perfused transcardially with a 
fixative solution containing 1% paraformaldehyde (PFA) and 0.2% glutaraldehyde in 0.1M 
phosphate buffer (PB) at pH = 7.4. Next, animals received a craniotomy; the brains were 
removed from the skull, and the striatum was microdissected from the brain and post-fixed 
in the same perfusate solution (1% PFA and 0.2% glutaraldehyde) overnight at 4oC. The 
striatum was cut on a vibrating microtome (Leica VT1000S) into 100 µm coronal sections.  
Pre-Embedding & Labeling of VGLUT2 
 To study the ultrastructural characteristics and distribution of VGLUT2 in the 
striatal neuropil of the mouse dorsal striatum, tissue was labelled using 
immunohistochemical procedures. The 100 µm sections were incubated in 50mM glycine 
for 1 h to expose binding sites for antigen retrieval. Sections were then pre-blocked for 1 h 
in 5% normal donkey serum (NDS), 5% bovine serum albumin (BSA), and 0.025% Triton-
x to further improve antigen access. Next, sections were incubated in a primary polyclonal 
antibody against VGLUT2 (guinea pig; 1:2000, Synaptic Systems) diluted in 1% NDS, 
0.2% acetylated BSA (BSA-c, Aurion), and 0.025% Triton-x, overnight at 4oC. Tissue was 
microwaved in the Pelco Biowave Pro oven (Biowave; Ted Pella Inc., Redding, CA) at a 
low wattage (150 W for 10 min at 25oC) to assist with antibody penetration into tissue. 
All sections were next incubated in a secondary biotinylated antibody (donkey anti-
guinea pig IgG; Jackson ImmunoResearch) overnight at 4oC with one microwave session 
(150W for 10 min at 25oC). After rinsing the tissue 3 x 10 min in 0.1M PB, sections were 
incubated in an Avidin-Biotin-HRP solution (AB-HRP kit; Vector Elite PK-6100, Vector 
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Laboratories) for 1 h at 4oC. Finally, sections were incubated in a 3’-diaminobenzine 
(DAB) and hydrogen peroxide solution (DAB kit; Vector Laboratories) for 3 min at 25oC. 
Staining of the tissue with DAB initiated peroxidase-catalyzed polymerization of DAB. 
The immunoperoxidase reaction was terminated by washing the tissue in 0.3% H2O2 in 0.1 
M PB and sections were then processed for the reaction. Following pre-embedding, tissue 
was rinsed in PB and post-fixed in 4% PFA and 6% glutaraldehyde in 0.1M phosphate 
buffer (PB) using the microwave (150-250W for 2-5 min). When the temperature of the 
tissue reached 30oC, the tissue was rinsed three times in 0.1 M cacodylate buffer over the 
duration of 1 h prior to EM processing and embedding. 
Tissue Processing & Embedding for Serial Block Face Imaging 
Tissue was processed for serial block face EM according to protocol modified from 
(Wang & Barbas, 2018). On day 1, sections were incubated in a solution comprised of 
0.1% tannic acid in 0.1M cacodylate buffer for 30 min at room temperature (RT). Then, 
the tissue was osmicated in a 2% osmium tetroxide (OsO4) solution containing 1.5% 
potassium ferricyanide (KFeCN) in 0.1M cacodylate buffer. Incubation in OsO4 enables an 
oxidation reaction to occur in unsaturated bonds of fatty acids, adding density and contrast 
to tissue samples (Chissoe et al., 1995). The addition of reducing agent KFeCN with OsO4 
serves to enhance the contrast of membrane bound organelles such as mitochondria. After 
a microwave session (100W for 6 min total) and 30 min on the rotator, the tissue was 
incubated in 1% thiocarbohadryzide (TCH) in dH2O for 20-30 min. Next, sections were 
transferred to a 2% OsO4 solution in dH2O and incubated using microwave assistance 
(100W for 6 min total), followed by 30 min in the rotator. 
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Tissue was then counterstained en bloc in 1% uranyl acetate (UA) in dH2O for 1-
2.5 h. Staining with UA generated a high electron density for clear contrast visualization 
of cell membranes and proteins within the striatal neuropil.  Sections were then submerged 
in a lead aspartate solution (0.04g L-aspartic acid / 10mL) for 30 min in a 60oC oven. Next, 
tissue was dehydrated in an ascending series of alcohols (50, 75, 85, 95% EtOH). For each 
series of alcohol, tissue was dehydrated for 10 minutes before the next alcohol was 
introduced. After dehydration, all tissue was rinsed in propylene oxide before being 
transferred into 20cc glass scintillation vials. Finally, all tissue was incubated in an expoxy 
resin solution (1:1 EM112 resin: propylene oxide) at RT for 1 h. The propylene oxide 
served as an intermediate solvent to aid in the transition between alcohol dehydration and 
the infiltration of resin into the tissue. The tissue was left overnight at RT in a dark fume 
hood. The next day, DMP-30 was mixed with the resin solution to accelerate resin 
infiltration into the tissue. After 15 minutes, tissue was transferred to a 100% accelerated 
epoxy resin solution for 4-6 h. Sections were then flat embedded in EM112 resin in between 
Aclar plastic (Ted Pella) sheets before being cured in a 60oC oven for 48-72 hrs.    
Serial Block Face 3D Electron Microscopy 
 The dorsal striatum was micro-dissected from each EM112-embedded tissue to 
obtain blocks of embedded tissue with a 100x100 micron block face. These micro-dissected 
resin tissue blocks were sent to Renovo Neural (Cleveland, OH) for serial block face 
imaging, with similar specifications as previously described (Chen et al., 2014). All tissue 
was imaged using a Carl Zeiss Sigma VP scanning electron microscope equipped with a 
3-View in-chamber ultramicrotome system. The microscope contained a Gatan high 
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sensitivity, backscattered electron detector (Gatan, England) that uses a 2.25 low-kV beam 
in high vacuum mode to detect images. The surface of each block of tissue embedded in 
resin is imaged by detecting back-scattered electrons from the tissue. Once the surface of 
the block was scanned, the ultramicrotome was automated to cut the block of tissue at 0.07 
µm (70 nm) z-intervals. Tissue cutting and imaging was done at 6,000x magnification until 
serial stacks of 250-500 images of the striatal neuropil were obtained. 
Synapse Characterization & 3D EM Reconstructions  
 As part of this study, a total of five datasets were examined. Each dataset belonged 
to a different wildtype or Q175+/- mouse. Aligned serial images from Renovo were 
analyzed using the ReconstructTM software (http://synapses.clm.utexas.edu; Fiala et al., 
2001; RRID:SCR_002716) as previously described (Medalla & Barbas, 2009). In all the 
datasets examined, all images had a resolution of 4.5 nm per pixel. Among all datasets, 23 
fields were randomly generated and selected to be designated counting areas for synapse 
characterization and 3D reconstruction. Each field has a dimension of 8 x 8µm (area = 64 
µm2 / field) and spanned 3.5 µm in the z-direction. For each animal, immunolabeled 
VGLUT2+ and VGLUT2- axon terminals and excitatory axospinous synapses were 
identified and quantitatively characterized within the designated counting fields.  
Axon terminals were identified based on the presence of DAB. While DAB is the main 
focus of this study, other chromogens such as 3,3’,5,5’-Tetramethylbenzidine (TMB) and 
gold conjugated particles (mHTT) were used during the EM embedding and staining 
procedures as part of previous studies for identification of D2 receptors and mHTT 
respectively. On individual electron micrograph images, proteins and nucleic acids found 
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at DAB positive axon terminals contain a dark precipitate. Reconstructed synapses 
containing the dark DAB precipitate were categorized as VGLUT2+ while synapses 
lacking the precipitate were categorized as VGLUT2-. After DAB was identified in 
synaptic elements within the counting fields, object contours were generated for all 
elements through the entirety volume of the counting field. The presence of DAB was 
validated by other colleagues with extensive experience with EM reconstruction methods. 
All researchers were blinded to the animal’s genotype during data acquisition. 
 
Confocal Microscopy Studies of Thalamostriatal Afferents 
 
Selection of Regions of Interest 
To examine the optical density and distribution of VGLUT2 thalamostriatal axon 
terminals and colocalization with mHTT in the striatal neuropil, tissue sections from three 
levels of the striatum in each animal were selected for immunohistochemical dual labelling 
of VGLUT2 and mHTT. Frozen 50 µm sections were selected from a series of tissues 
obtained from mouse brains previously perfused with 4% paraformaldehyde. For each 
animal, three tissue sections were chosen based on their anatomical position within the 
dorsolateral striatum in the rostral to caudal direction: rostral, middle, and caudal. All slices 
were selected with reference to coronal Nissl sections (sections 21 to 35) of the mouse 
striatum as seen in the Atlas of the Mouse Brain and Spinal Cord (Sidman, Angevine, & 
Pierce, 1971). The approximate appearance and scanned area for selected rostral, middle, 
and caudal coronal sections are shown in similar Nissl stains shown in Figure 5. 
Figure 5: Regions of interest in the mouse 
striatum as seen on coronal sections. Cor-
onal sections of the mouse brain at the level of 
the caudate and putamen (yellow arrow) show 
representative Nissl-stains (left) and color-cod-
ed anatomical regions (right) of the rostral (A), 
middle (B), and caudal (C) levels of the striatum. 
Black arrows indicate the location of the later-
al ventricle. Red box demarcates the approxi-
mate region (dorsal and lateral to the VL) that 
tissue was scanned. All images obtained from 
the Mouse Brain Connectivity Atlas (Allen Insti-
tute for Brain Science, 2011). Abbreviations: CP, 





Immunofluorescence Labeling of mHTT & VGLUT2 
To study the density, distribution, and colocalization of VGLUT2 and mHTT 
within the dorsolateral striatum from the rostral to caudal direction, selected tissue was 
processed using immunohistochemical procedures. 50 µm sections were incubated in 
50mM glycine and then placed in a water bath at 50-60oC for 1 h to unmask antigen binding 
sites for retrieval. Sections were then pre-blocked for 1 h in 0.01M PBS (ph = 7.4-7.5), 5% 
normal donkey serum (NDS), 5% bovine serum albumin (BSA), and 0.025% Triton-x to 
further improve antigen access. Next, sections were incubated in an antibody incubation 
buffer containing 0.1M PB (no saline), 0.2% acetylated BSA, 1% NDS (Vector/Jackson 
Labs), 0.1% Trixon-X along with primary monoclonal antibodies against VGLUT2 (guinea 
pig; 1:1000) and mHTT (mouse anti-EM48; 1:500). Tissue was then microwaved in the 
Pelco Biowave Pro oven (Biowave; Ted Pella Inc., Redding, CA) at a low wattage (2x at 
150 W for 10 min at 40oC) and left to incubate overnight at 4oC. The next day, tissue was 
washed and then incubated in the same antibody incubation buffer with fluorescent 
secondary antibodies against VGLUT2 (donkey anti-guinea-pig 647; 1:200) and mHTT 
(donkey anti-goat 488, 1:200) primary antibodies. After the tissue incubated overnight at 
4oC, all sections were mounted, and cover slipped onto glass slides with Prolong Anti-Fade 






Tissue Imaging with Confocal Laser Scanning Microscopy 
 For confocal microscope analyses, tissue was imaged using a Leica TCS SPE high-
resolution optical microscope. Since images from confocal microscope analyses were not 
used for reconstructions, tile scans were done to ensure a wide field of the dorsolateral 
striatum was imaged. All tiles were stitched together using the auto-stitching tool in Leica 
Microsystem’s LAS X scanning software, creating a single continuous image with 
dimensions of 4 x 2 tiles. All images were scanned using a 40x objective in an oil 
immersion medium, with a voxel size of 0.13434 x 0.13434 x 0.5 µm and a 1.3 numerical 
aperture. Positions were marked in the software to denote the region of the dorsolateral 
striatum that was scanned. After a 4 x 2 tile area was demarcated in the dorsolateral 
direction relative to the lateral ventricle, the gain, offset, and z-compensation settings were 
adjusted for each laser channel to ensure that fluorescence was visible throughout the entire 
volume of each tissue section. The scanning resolution for each tile was set to 2048 x 2048 
pixels. Each scan took around 1 hour to complete. All scanned images were exported into 
Autoquant X3 software for deconvolution. Images from two channels (546, 647) were 
deconvolved separately to removes optical distortions to the images caused by light 
scattering and other sources of noise that were present during tissue imaging. After the 
image quality was improved, all files were exported as 8-bit TIFF files. Images were then 





Particle & Colocalization Analyses in ImageJ 
 Each 8-bit TIFF file contained a confocal stack that spanned the length of 40-60 
µm. To ensure an equal volume of tissue was examined across all tissue sections, all 
channels in the confocal stack were merged and sub-stacked from the middle to create a 20 
µm RBG stack in ImageJ. For each image in the sub-stack, an ROI detector ImageJ macro 
was used. First, a large general ROI of the dorsolateral striatum was manually drawn to 
narrow down the area for analyses to be performed. Then, five ROIs with the dimensions 
of 67 µm x 67 µm (500 x 500 pixels) were randomly generated by the macro within the 
manually generated ROI. The randomly placed ROIs were saved and imported for particle 
analysis and colocalization. Next, another ImageJ macro was used for quantification and 
colocalization analyses. For each tissue section, the minimum threshold value for 
immunolabeled particle detection was manually set for each channel. The “RenyiEntropy” 
automated thresholding method was used to assist with setting the threshold value. Before 
channel thresholds were set for particle analysis, the automated threshold was tested to see 
if particles were detected and adjusted if necessary.  
After thresholds for particle detection were set for each channel, the optical density 
of mHTT+ and VGLUT2+ immunolabelled particles were determined in separate particle 
analyses within each of the five randomly placed ROIs using the particle analysis plugin 
in ImageJ (RRID:SCR_003070; Schneider et al., 2012). For each section, only particles 
with intensity values above the set threshold were quantified. Quantitative measurements 
such as particle count, total area, average size, and fractional area of all particles were 
generated for each ROI through the entirety of the 20 µm confocal stack. The optical 
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density of particles with overlapping mHTT+ and VGLUT2+ immunolabel were quantified 
in the same way using the EzColocalization plugin (Stauffer et al., 2018). All data was 
exported as .csv files to MATLAB. 
Statistical Analyses 
 From EM studies, quantitative area and volumetric ultrastructural features of 3D 
reconstructed pre- and post-synaptic elements were categorized based on three categorical 
variables. The two main variables were: genotype (wildtype or Q175+/-), and VGLUT2 
marker (based on the presence or absence of DAB in the axon terminal, denoted by 
VGLUT2+ or VGLUT2- respectively). Comparisons of general synapse characteristics, 
synapse density and size distribution were also done using these two variables. For the 
subset of pre-synaptic boutons containing mitochondria, synapses were additionally 
categorized based on mitochondria morphology (normal or damaged). The five 
ultrastructural features were: pre-synaptic bouton volume, pre-synaptic mitochondria 
volume, post-synaptic spine volume, PSD area, and number of post-synaptic spines 
associated with each pre-synaptic bouton. All raw area and volumetric quantifications of 
object contours were tabulated on a Microsoft Excel spreadsheet. The mean, standard 
deviation, and standard errors were calculated for each feature. Raw data tables were 
exported as .csv files and imported into MATLAB where all data analyses were performed.  
Comparisons were done on all quantitative features based on categorical variable groups 
using two-tailed Student’s T tests. Differences of synapse size are shown on boxplots. 
Differences of synapse density are represented on scatter plots. Linear regression analyses 
were performed to assess relationships between pre- and post-synaptic ultrastructural 
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features for VGLUT2+ and VGLUT2- synapses. All features were expressed as Pearson 
product-moment coefficients for a first-degree polynomial. Initially, the ultrastructural 
measurements were not normally distributed. With the removal of outliers beyond three 
standard deviations from the mean and a log transformation of the data, quartile-quartile 
plots and Kolmogorov-Smirnov (K-S) tests confirmed that the data was normally 
distributed. Each ultrastructural feature was divided into 15 equally spaced bins. Binned 
data was used to generate normalized relative and cumulative frequency functions to 
examine differences in synapse size distribution based on genotype. Standard error values 
were calculated per bin and shown on the error bars. Two-tailed student T tests were done 
to compare size values between genotypes based on bin. To assess whether the levels of 
each categorical variable significantly influence changes observed among ultrastructural 
features, combinations of two categorical variables (each with two levels) and one 
dependent ultrastructural feature were inputted in nine separate 2x2 factorial analysis of 
variances (ANOVA) tests. All ANOVAs followed an unbalanced design without 
replication and computed constrained Type III sum of squares using the anovan function 
in MATLAB. Bonferroni post hoc tests were performed to assess significant interactions 
and effects.  
For confocal microscopy studies, all .csv files from ImageJ particle and 
colocalization analyses were imported into MATLAB. Data was divided into three groups 
based on the region of the striatum along the rostral to caudal direction: rostral, middle, 
and caudal. For each section, the average optical densities of mHTT (channel 2: 546) and 
VGLUT2 (channel 3: 647) was computed for each ROI across the entire 20 µm image 
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stack. For each section, the average fractional percent area of each ROI mean was 
computed to determine the mean particle density values for each channel. The same steps 
were performed for computing the density of dual labelled VGLUT2 / mHTT particles. To 
assess distribution of synaptic density based on anatomical location within the striatum, 
between and within-species comparisons of VGLUT2 distribution were performed for each 
region of the striatum. Similar within-species comparisons were made for mHTT and dual 
labelled VGLUT2/mHTT density distribution among Q175+/- sections to determine 
whether significant regional differences are seen in the striatum. All figures were generated 
in MATLAB. The threshold of significance was set to a = 0.05 for all statistical and post 




3D EM Reconstructions of VGLUT2+ & VGLUT2- Synapses 
Serial electron microscopy was used to characterize the distribution and 
ultrastructural properties of VGLUT2+ and VGLUT2- boutons forming excitatory 
asymmetric synapses (VGLUT2+ and VGLUT2- synapses) in the striatal neuropil of 
wildtype and Q175+/- animals. A total of 288 boutons with axospinous synapses (106 
wildtype, 182 Q175+/-) from 5 subjects (2 wildtype, 3 Q175+/-) were reconstructed in 3D 
using ReconstructTM software. DAB was used to immunolabel VGLUT2 (see methods). 
Differences between VGLUT2+ and VGLUT2- synapses as they appear on EM 
micrographs can be seen in Figure 6. In total, 138 VGLUT2+ (56 wildtype, 82 Q175+/-) 
and 150 VGLUT2- (50 wildtype, 100 Q175+/-) synapses were reconstructed. All synapses 
were characterized from 23 randomly placed counting fields. A total area of 1,472 µm2 
was analyzed, equating to a total volume of 1,030.4 µm3. While the relative number of 
characterized VGLUT2+ and VGLUT2- synapses were similar, all wildtype synapses 
came from 5 of 23 counting frames (sectional area = 320 µm2; volume = 224 µm3).  
For this study, only axospinous excitatory synapses were characterized. All 
axodendritic synapse characteristics collected during data acquisition stage were omitted 
from statistical analyses. Criteria for consideration for excitatory synapses include the 
presence of these synaptic elements: a wide synaptic cleft, asymmetric pre- and post-
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synaptic elements, round synaptic vesicles, and a dense post-synaptic density (PSD) (Peters 
et al., 1991). Identified excitatory synapses were evaluated for completeness as follows – 
it must be composed of complete pre-synaptic bouton, post-synaptic spine, and PSD. 
Complete synapses typically span ~10-30 serial sections in our datasets. For each synapse, 
shape contours were generated for pre-synaptic boutons and post-synaptic spines. Line 
contours of the synapse at the junction between the pre-synaptic bouton and PSD were also 
created. Specific morphological features were identified to further characterize the 
synapses. All completed synapses were defined based on their genotype (wildtype or 
Q175+/-), whether the synapses have a non-perforated (continuous) or a perforated 
(interrupted) PSD, whether the pre-synaptic bouton was multi-synaptic (MSB), the number 
of mitochondria found within the pre-synaptic bouton, and if the mitochondria were normal 
or damaged. Mitochondria were considered damaged if there was evidence of 
morphological alterations such as mitochondrial fission, fragmentation, and disorganized 
dilated cristae (Costa et al., 2010). All object contours and characterizations were made for 
the entire volume of each synapse and can be seen on EM micrographs. ReconstructTM 
software was used to generate a 3D model (Virtual Reality Modeling Language) of all 
synapses. Object contours of synaptic elements in different counting fields (Fig. 7A) and 
individual wildtype (Fig. 7B, C) and Q175 (Fig. 7D, E) axospinous synapses were rendered 
and observed in 3D. 
Figure 6: EM micrograph of VGLUT2+ & VGLUT2- axon terminals. Counting frame 
of an EM micrograph showing the difference between a VGLUT2+ synapse (blue arrow) 
and a VGLUT2- synapse (red arrow). The characteristic dark precipitate of DAB can be 
seen within the round vesicles of the soma in the VGLUT2+ synapse. Scale: 0.5 microns
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0.5 microns
Figure 7: 3D model of reconstructed axospinous synapses. Object contours 
(red & orange: pre-synaptic boutons; blue & cyan: dendritic spines; green: mito-
chondria; yellow: area of synapse between the PSD and pre-synaptic bouton) of 
reconstructed VGLUT2+ and VGLUT2- synapses from 4 randomly placed counting 
fields (magenta) in a wildtype mouse (A). 3D reconstructed wildtype axospinous 
synapse associated with one dendritic spine (B), two dendritic spines and two mi-
tochondria (C). 3D reconstructed Q175 axospinous synapse associated with two 
dendritic spines and fragmented mitochondria (D), two dendritic spines and elon-
gated mitochondria (E). Red: pre-synaptic boutons; Blue: dendritic spines; green: 
mitochondria; yellow: area of synapse between the PSD and pre-synaptic bouton. 
Scale cube: 0.7 x 0.7 x 0.7 microns  
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Characterization of VGLUT2+ & VGLUT2- Synapses 
For each element in a counted synapse, volumetric measurements of pre-synaptic 
boutons, pre-synaptic mitochondria, and post-synaptic spines were exported in addition to 
area measurements of the synaptic junction of the PSD. After object contours were created 
for all synaptic elements, ultrastructural variables were quantitatively compared between 
wildtype and Q175+/- animals were performed (Table 1). Characterization of synapses
shows that the proportion of macular (n = 33) and perforated (n = 23) VGLUT2+ synapses 
did not differ in wildtype animals (Fig. 8A). Additionally, 20% of all wildtype boutons 
were multi-synaptic (now referred to as MSB) (n = 17), synapsing onto two or more post-
synaptic spines (Fig. 8B). In Q175+/- animals there was a higher proportion of macular (n
= 66) than perforated (n = 16) synapses (Fig. 8A). Relative proportions of multi-synaptic 
boutons in Q175+/- animals (n = 18) were comparable to the wildtype group, consisting of
22% of all reconstructed pre-synaptic boutons (Fig. 8B). 
The ultrastructural properties of VGLUT2- axospinous synapses were also 
compared between wildtype and Q175+/- animals. The proportion of macular (n = 27) and
perforated (n = 23) VGLUT2- synapses did not differ in wildtype animals (Fig. 8C), with 
MSBs (n = 10) making up 20% of all reconstructed boutons (Fig. 8D). In Q175+/- animals,
there was a higher proportion of macular (n = 63) than perforated (n = 37) synapses (Fig. 
8C). Relative proportions of multi-synaptic boutons in Q175+/- animals (n = 24) did not
differ from the wildtype group (Fig. 8D).  










wildtype (n = 56) 0.99 ± 0.07 0.13 ± 0.01 0.36 ± 0.03 0.30 ± 0.02 
Q175+/- (n = 82) 0.88 ± 0.04 0.10 ± 0.006 * 0.19 ± 0.01 *** 0.24 ± 0.01 * 










wildtype (n = 50) 0.73 ± 0.07 0.10 ± 0.01 0.26 ± 0.04 0.24 ± 0.02 
Q175+/- (n = 100) 0.85 ± 0.04 0.08 ± 0.004 0.28 ± 0.02 0.28 ± 0.02 
Table 1: Means (± SEM) of VGLUT2+ & VGLUT2- ultrastructural features. Averages for 
VGLUT2+ (top) and VGLUT2- (bottom) axospinous synapses given with SEM. No significant 
differences found in VGLUT2- wildtype and Q175+/- groups. Spine volume: p = 1.02 x 10-6; 
Mitochondria volume: p = 0.035; PSD Area: p = 0.019. * p < 0.05; ** p < 0.005; *** p < 0.0005 
40 
41
Figure 8: Morphology and targets of VGLUT2+ and VGLUT2- boutons. Rela-
tive proportions of VGLUT2+ boutons (A, B) forming macular and perforated syn-
apses (A) and multi-synaptic and single synapses on spines (B) in wildtype (left, 
blue) and Q175 (right, red) groups. Relative proportions of VGLUT2- boutons (C, 
D) forming macular and perforated synapses (C) and multi-synaptic and single 
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For VGLUT2+ pre-synaptic boutons containing mitochondria, 32% (n = 11) of 
synapses had the appearance of being damaged in wildtype and 65% (n = 48) had this 
appearance in Q175+/- synapses (Fig. 9A). In VGLUT2- pre-synaptic boutons containing 
mitochondria, 21% (n = 4) and 71% (n = 55) of the mitochondria appeared damaged in 
wildtype and Q175+/- animals respectively (Fig. 9B). Quantitative comparisons of 
mitochondria volume revealed only a significant difference in VGLUT2+ boutons – 
Q175+/- mitochondria pre-synaptic mitochondria were significantly smaller compared to 
wildtype (mitochondria volume: p = 0.04, Fig. 9C). Characteristics of normal versus 
damaged mitochondria can be seen on electron micrograph sections (Fig. 9D, E) as well as 
in the 3D reconstructed mitochondria (Fig. 9F, G). Damaged mitochondria in both Q175+/- 
VGLUT2+ and VGLUT2- pre-synaptic boutons consistently demonstrate fragmentation 
from a single whole element to smaller “pea-shaped” fragments (Fig. 9D, F). Elongation 
of mitochondria was also observed (Fig. 9E, G). Results support observations of reduced 
volume and aberrant mitochondria morphology observed in the striatum of the YAC128 


































































































of mitochondria. Relative proportions of normal and 
damaged mitochondria in VGLUT2+ (A) and VGLUT2- (B) 
boutons of wildtype (left, blue), and Q175 (right, red) dor-
sal striatum.Comparisons of average mitochondria vol-
ume between wildtype and Q175 mice in VGLUT2+ (left) 
and VGLUT2- (right) boutons (C). Electron micrographs 
showing signs of mitochondrial fission (red arrows) in 
VGLUT2+ synapses, including fragmentation into smaller 
elements (D) and abnromal elongation (E) 3D reconstruc-
tions for mitochondria in (D) and (E) (F, G). * p < 0.05. 
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Comparison of VGLUT2+ & VGLUT2- Synapse Size 
 To assess differences in synapse size between VGLUT2+ and VGLUT2- synapses, 
comparisons of pre-synaptic bouton volume, post-synaptic spine volume, and PSD area 
across were made between wildtype and Q175+/- groups. VGLUT2+ post-synaptic spine 
volume and PSD area revealed significant differences (all p < 0.05, Student’s T test) 
between wildtype and Q175+/- groups (spine volume: p = 1.02 x 10-6, Fig. 10B; PSD area: 
p = 0.019, Fig. 10C). No differences between genotypes were observed for pre-synaptic 
bouton volume in VGLUT2+ synapses (Fig. 10A). Additionally, no differences between 
genotypes were for any ultrastructural features of VGLUT2- synapses. These results 
support previous findings demonstrating no change in pre-synaptic terminal size, but 
significant reductions in post-synaptic spine size at VGLUT2+ immunolabeled terminals 










Figure 10: Comparison of VGLUT2+ & VGLUT2- synapse size. Box and whis-
ker plots showing wildtype (blue) and Q175 (red) comparisons for VGLUT2+ (left) 
and VGLUT2- (right) bouton volume (A), and their associated spine volumes (B), 













































































Distribution of VGLUT2+ & VGLUT2- Synapse Size 
To examine the distribution of VGLUT2+ and VGLUT2- synapse sizes, all 
features were divided into 15 bins. The relative frequency (number of measurements per 
bin / total number of measurements) was calculated per bin between wildtype and 
Q175+/- mice for VGLUT2+ (Fig. 11) and VGLUT2- synapses (Fig. 12). For bouton 
volume, there were significant differences in bin 3 (wildtype: 0.49 ± 0.01 µm3, Q175+/-: 
0.55 ± 0.01 µm3; p = 0.01; Fig. 11A) and bin 5 (wildtype: 0.81 ± 0.02 µm3, Q175+/-: 0.67 
± 0.008 µm3; p = 0.03; Fig. 11A). For mitochondria volume, there was a significant 
difference in bin 9 (wildtype: 0.17 ± 0.0007 µm3, Q175+/-: 0.16 ± 0.001 µm3; p = 0.005; 
Fig. 11C). For spine volume, there were significant differences in bin 5 (wildtype: 0.27 ± 
0.004 µm3, Q175+/-: 0.29 ± 0.005 µm3; p = 0.01; Fig. 11B) and bin 6 (wildtype: 0.36 ± 
0.001 µm3, Q175+/-: 0.34 ± 0.005 µm3; p = 0.01; Fig. 11C).  
For PSD area, there was a significant difference in bin 3 (wildtype: 0.19 ± 0.004 
µm2, Q175+/-: 0.17 ± 0.003 µm2; p = 0.04; Fig. 11D). There was a leftward shift (higher 
frequency of smaller spines) for the cumulative distribution of VGLUT2+ Q175+/- spine 
volumes relative to wildtype (Kolmogorov-Smirnov test, p = 0.03; Fig. 11B). No other 
leftward shifts were seen. Among VGLUT2- synapses, the frequency distributions were 
not different between wildtype and Q175+/- features except for spine volume (Fig. 12C) 
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where differences were observed in bin 1 (wildtype: 0.05 ± 0.006 µm3, Q175+/-: 0.08 ± 
0.005 µm3; p = 0.01), bin 4 (wildtype: 0.29 ± 0.008 µm3, Q175+/-: 0.32), and bin 8 
(wildtype: 0.63 ± 0.002 µm3, Q175+/-: 0.64 ± 0.01 µm3; p = 0.03). 
Figure 11: Distribution of VGLUT2+ ultrastructural features. Relative frequen-
cy (main) and cumulative distribution (upper right) based on binned measurements 
of bouton volume (A), mitochondria volume (B), spine volume (C), and PSD area 
(D). * p < 0.05
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Figure 12: Distribution of VGLUT2- ultrastructural features. Relative frequency 
(main) and cumulative distribution (upper right) based on binned measurements of 
bouton volume (A), mitochondria volume (B), spine volume (C), and PSD area (D). 
* p < 0.05
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Density of VGLUT2+ & VGLUT2- Synapses 
 To estimate differences in the spatial abundance between VGLUT2+ & 
VGLUT2- synapses in wildtype and Q175+/- mice, a size frequency method from 1975 
was employed to calculate the numerical density of all synapses (Colonnier & Beaulieu, 
1985). This method has been previously used in our lab for quantification of synapse 
density in EM micrographs (Peters, Sethares, & Luebke, 2008). To calculate synapse 
density, the empirical formula NV = NA / D is used. NV represents the number of 
synapses per unit volume, NA represents the number of synaptic junctions per unit area of 
a random counting field on an EM micrograph, and D represents the average length of 
PSD line contours that are associated with the synaptic junction. Comparisons of synaptic 
densities between wildtype and Q175+/- mice (all p < 0.05, Student’s T test) reveal ~2x 
reductions in synapse density in Q175+/- mice for both VGLUT2+ (p < 0.05; Fig. 13) and 
VGLUT2- (p < 0.05; Fig. 13) synapses. The same ~2x reduction was also observed in a 
between all wildtype and Q175+/- synapses (p < 0.05). All density values are reported in 















                                                        
 VGLUT2+ 
(synapses / mm3) 
VGLUT2- 




wildtype 0.20 ± 0.02 0.23 ± 0.02 0.42 ± 0.02 
Q175+/-   0.10 ± 0.01 *   0.11 ± 0.02 *   0.22 ± 0.01 * 
 
Table 2: Means (± SEM) of VGLUT2+ & VGLUT2- synapse density in the dorsal 
striatum. Average VGLUT2+ (left), VGLUT2- (middle) and total (right) synapse 




Figure 13: Density of VGLUT2+ & VGLUT2- synapses. Numerical density per 
unit volume of all (VGLUT2+ & VGLUT2-) synapses (left), VGLUT2+ synaps-
es (middle), and VGLUT2- synapses (right), in wildtype (blue) and Q175 (red) 
groups. * p < 0.05  




























Relationships Between Pre- & Post-Synaptic Elements 
To assess whether the properties of 3D reconstructed pre-synaptic elements were 
related to their respective post-synaptic elements, linear regression analyses for pre-
synaptic bouton volume x post-synaptic spine volume; pre-synaptic bouton volume x PSD 
area; and post-synaptic spine volume x PSD area were performed for both VGLUT2+ and 
VGLUT2- ultrastructural features in wildtype and Q175+/- mice (Figure 14). After 
performing linear regression analyses between bouton volume and spine volume, positive 
correlations were seen for both VGLUT2+ (wildtype, r = 0.56; Q175+/-, r = 0.32; p < 0.01; 
Fig. 14A, left) and VGLUT2- synapses (wildtype, r = 0.69; Q175+/-, r = 0.39; p < 0.01; 
Fig. 14A, right). Regression analyses examining the relationship between bouton volume 
and PSD area also demonstrated positive correlations for VGLUT2+ synapses (wildtype, r 
= 0.54; Q175+/-, r = 0.46; p < 0.01; Fig. 14B, left), with stronger positive correlations 
among VGLUT2- synapses (wildtype, r = 0.63; Q175+/-, r = 0.60; p < 0.01; Fig. 14B, right). 
The strongest positive correlations were seen between PSD area and spine volume in 
VGLUT2+ (wildtype, r = 0.82; Q175+/-, r = 0.72; p < 0.01; Fig. 14C, left) and VGLUT2- 
synapses (wildtype, r = 0.90; Q175+/-, r = 0.77; p < 0.01; Fig. 14C, right). 
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Figure 14: Linear regressions of VGLUT2+ & VGLUT2- ultrastructural fea-
tures. Scatterplots demonstrating relationships between pre- and post-synaptic 
features for VGLUT2+ (left) and VGLUT2- (right) synapses ultrastructural features: 
bouton volume x spine volume (A), bouton volume x PSD area (B), spine volume 





Relationship Between Group Characteristics & Ultrastructural Features 
 To assess the relationships between synapse categorical variables and 
ultrastructural features, a total of ten two-way unbalanced ANOVAs without replication 
were performed. The first seven ANOVAs were performed with two categorical factors, 
each with two levels: genotype (wildtype, Q175+/-), and VGLUT2 marker (VGLUT2+, 
VGLUT2-). The first three ANOVAs examined the relationship between the two 
categorical factors and the following ultrastructural features for all synapses (n = 288): 
bouton volume, spine volume and PSD area. The next four ANOVAs examined the same 
relationships, but with the addition of an ANOVA for mitochondria volume in synapses 
containing mitochondria (n = 182). Output tables for these ANOVAs are found in Table 3. 
For the ANOVAs of bouton volumes among all synapses, the main effect genotype 
was not significant (F [1, 284] = 2.16, p > 0.05) while the main effect of VGLUT2 marker 
was significant (F [1, 284] = 10.28, p = 0.0015; Table 3A), suggesting that the average 
bouton volume was significantly larger in all VGLUT2+ synapses (0.93 ±  0.04 µm3) than 
in all VGLUT2- (0.81 ± 0.03 µm3) synapses. The interaction between genotype and 
VGLUT2 marker was significant (F [1, 284] = 5.7, p = 0.0176; Table 3A), suggesting that 
the effect of VGLUT2 marker was greater in wildtype boutons than in Q175+/- boutons (p 
= 0.003). In analyses for mitochondria-containing synapses, the main effect of genotype 
was significant (F [1, 179] = 6.56, p = 0.0113; Table 3D) while the main VGLUT2 marker 
was not significant (F [1, 179] = 3.5, p > 0.05; Table 3D), suggesting that the average 
bouton volume was significantly larger in wildtype synapses (1.18 ± 0.07 µm3) than in 
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Q175+/- synapses (0.95 ± 0.03 µm3). No significant interaction was observed between 
genotype and VGLUT2 marker (F [1, 179] = 0.79, p > 0.05; Table 3D). 
ANOVAs of spine volume did not yield significant main effects for genotype (F [1, 
284] = 2.45, p > 0.05) or VGLUT2 marker (F [1, 284] = 1.15, p > 0.05), but a significant 
interaction (F [1, 284] = 23.55, p = 2.01 x 106; Table 3B) suggests that the effect of 
genotype was greater in VGLUT2+ than VGLUT2- spines (p = 0.0001) for all synapses. 
The same analyses for synapses with mitochondria yielded a significant main effect for 
genotype (F [1, 179] = 13.1, p = 0.0004; Fig. 15F), but not for VGLUT2 marker (F [1, 179] 
= 0.8154, p > 0.05; Table 3F), suggesting that the average spine volume was significantly 
larger in wildtype synapses (0.43 ± 0.04 µm3) than in Q175+/- synapses (0.25 ± 0.01 µm3). 
ANOVAs for PSD areas among all synapses reveal no significant main effects for genotype 
(F [1, 284] = 0.06, p > 0.05; Table 3C) or VGLUT2 marker, (F [1, 284] = 1.1, p > 0.05; 
Table 3C). However, a significant interaction (F [1, 284] = 6.7, p = 0.0101; Fig. 15C) 
between the two categorical variables was initially reported but determined to be non-
significant after post hoc analyses (Bonferroni post hoc test, p > 0.05). When the same 
analyses were performed for PSD areas for synapses containing mitochondria, the same 
results were observed for genotype (F [1, 179] = 3.49, p > 0.05; Table 3G) and VGLUT2 
marker (F [1, 179] = 0.29, p > 0.05; Table 3G), and no significant interaction was reported 
(F [1, 179] = 3.59, p > 0.0; Table 3G). ANOVAs of mitochondria volume yielded a 
significant main effect of genotype (F [1, 179] = 4.28, p = 0.04; Table 3E), suggesting that 
the average mitochondria volume was significantly larger in wildtype boutons (0.12 ±  
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0.009 µm3) than in Q175+/- boutons (0.09 ± 0.004 µm3). The main effect for VGLUT2 
marker (F [1, 179] = 3.82, p > 0.05; Fig. 15E) and interaction (F [1, 179] = 0.1, p > 0.05; 
Table 3E), was not significant.  
In the remaining three ANOVAs, genotype (wildtype, Q175+/-) and mitochondria 
morphology (normal, damaged), were the categorical factors used for analyses of the same 
ultrastructural features used in the first three ANOVAs (Table 4). The features in these 
analyses were also from the subset of synapses containing mitochondria. Genotype was a 
significant main effect in all three analyses: bouton volume: F (1, 179) = 14.95, p = 0.0002; 
Table 4A; spine volume: F (1, 179) = 16.56, p = 0.0001; Table 4B; PSD area: F (1, 179) = 
4.86, p = 0.0287; Table 4C. All main effects suggest a pattern where the average 
ultrastructural feature was significantly larger in wildtype synapses with normal 
mitochondria (bouton volume: 1.18 ± 0.07 µm3; spine volume: 0.43 ± 0.04 µm3; PSD area: 
0.34 ± 0.03 µm2) when compared to Q175+/- synapses with normal mitochondria (bouton 
volume: 0.95 ± 0.03 µm3; spine volume: 0.25 ± 0.01 µm3; PSD area: 0.28 ± 0.01 µm2). 
Mitochondria morphology was only a significant main effect in the ANOVA for bouton 
volume (F [1, 179] = 5.47, p = 0.0205; Table 4A), suggesting the same pattern of larger 
wildtype boutons and smaller Q175+/- boutons as observed for the genotype main effect. 
In all three ANOVAs, no significant interactions were reported. ANOVAs results for 
genotype x VGLUT2 marker and genotype x mitochondria morphology are summarized in 
Figures 15 and 16 respectively. 
Table 3: 2x2 Factorial ANOVA output tables for Genotype x VGLUT2 Marker. 
ANOVA results examining ultrastructural features for all synapses: bouton vol-
ume (A), spine volume (B), PSD area (C). ANOVA results examining ultrastructural 
features for synapses containing mitochondria: bouton volume (D), mitochondria 
volume (E), spine volume (F), PSD area (G).
  Source                      Sum Sq.   d.f.   Mean Sq.     F     Prob>F
------------------------------------------------------------------------
   Genotype                    0.5726     1    0.5726      2.16   0.143 
   Vglut2 Marker               2.73       1    2.72996    10.28   0.0015
   Genotype * Vglut2 Marker    1.5132     1    1.51321     5.7    0.0176
  Error                       75.3935   284    0.26547                  
  Total                       79.2392   287                             
Analysis of Variance
Constrained (Type III) sums of squares.
Genotype x VGLUT2 Marker - Bouton VolumA
  Source                       Sum Sq.   d.f.   Mean Sq.     F     Prob>F
-------------------------------------------------------------------------
   Genotype                      1.33      1     1.33       2.45   0.1183
   Vglut2 Marker                 0.626     1     0.6257     1.15   0.2835
   Genotype * Vglut2 Marker     12.761     1    12.7608    23.55   0     
  Error                        153.901   284     0.5419                  
  Total                        167.988   287                             
Analysis of Variance
Constrained (Type III) sums of squares.
Genotype x VGLUT2 Marker - Spine VolumeB
  Source                       Sum Sq.   d.f.   Mean Sq.    F     Prob>F
------------------------------------------------------------------------
   Genotype                     0.0199     1    0.0199     0.06   0.8015
   Vglut2 Marker                0.3449     1    0.34493    1.1    0.2958
   Genotype * Vglut2 Marker     2.1066     1    2.10661    6.7    0.0101
  Error                        89.3049   284    0.31445                 
  Total                        91.4743   287                            
Analysis of Variance
Constrained (Type III) sums of squares.
Genotype x VGLUT2 Marker - PSD AreaC
  Source                       Sum Sq.   d.f.   Mean Sq.    F     Prob>F
------------------------------------------------------------------------
   Genotype                     1.0211     1    1.02105    6.56   0.0113
   Vglut2 Marker                0.5448     1    0.54481    3.5    0.063 
   Genotype * Vglut2 Marker     0.1228     1    0.12276    0.79   0.3757
  Error                        27.8614   179    0.15565                 
  Total                        29.962    182                            
Analysis of Variance
Constrained (Type III) sums of squares.
Genotype x VGLUT2 Marker - Bouton VolumD
Genotype x VGLUT2 Marker - Mitochondria Volume
  Source                       Sum Sq.   d.f.   Mean Sq.    F     Prob>F
------------------------------------------------------------------------
   Genotype                     1.335      1    1.33501    4.28   0.04  
   Vglut2 Marker                1.1904     1    1.19036    3.82   0.0523
   Genotype * Vglut2 Marker     0.0313     1    0.0313     0.1    0.7518
  Error                        55.8493   179    0.31201                 
  Total                        59.3365   182                            
Analysis of Variance
Constrained (Type III) sums of squares.
E
Genotype x VGLUT2 Marker - Spine Volume
  Source                       Sum Sq.   d.f.   Mean Sq.     F     Prob>F
-------------------------------------------------------------------------
   Genotype                      6.41      1    6.41045    13.1    0.0004
   Vglut2 Marker                 0.027     1    0.02676     0.05   0.8154
   Genotype * Vglut2 Marker      5.05      1    5.05024    10.32   0.0016
  Error                         87.587   179    0.48931                  
  Total                        101.097   182                             
Analysis of Variance
Constrained (Type III) sums of squares.
F
Genotype x VGLUT2 Marker - PSD Area
  Source                       Sum Sq.   d.f.   Mean Sq.    F     Prob>F
------------------------------------------------------------------------
   Genotype                     0.9816     1    0.98156    3.49   0.0633
   Vglut2 Marker                0.0822     1    0.08221    0.29   0.5893
   Genotype * Vglut2 Marker     1.0079     1    1.00789    3.59   0.0599
  Error                        50.3233   179    0.28114                 
  Total                        52.6636   182                            
An lysis of Variance
Constrained (Type III) sums of squares.
G
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  Source                                 Sum Sq.   d.f.   Mean Sq.     F     Prob>F
-----------------------------------------------------------------------------------
   Genotype                               2.302      1    2.30205    14.95   0.0002
   Mitochondria Morphology                0.8417     1    0.84172     5.47   0.0205
   Genotype * Mitochondria Morphology     0.1612     1    0.16122     1.05   0.3075
  Error                                  27.5567   179    0.15395                  
  Total                                  29.962    182                             
Analysis of Variance
Constrained (Type III) sums of squares.
Genotype x Mitochondria Morphology - Bouton Volume
  Source                                 Sum Sq.   d.f.   Mean Sq.     F     Prob>F
-----------------------------------------------------------------------------------
   Genotype                                8.518     1    8.51767    16.56   0.0001
   Mitochondria Morphology                 1.324     1    1.32404     2.57   0.1103
   Genotype * Mitochondria Morphology      0.107     1    0.10681     0.21   0.6491
  Error                                   92.043   179    0.51421                  
  Total                                  101.097   182                             
Analysis of Variance
Constrained (Type III) sums of squares.
Genotype x Mitochondria Morphology - Spine Volume
  Source                                 Sum Sq.   d.f.   Mean Sq.    F     Prob>F
----------------------------------------------------------------------------------
   Genotype                               1.3904     1    1.3904     4.86   0.0287
   Mitochondria Morphology                0.1623     1    0.16226    0.57   0.4523
   Genotype * Mitochondria Morphology     0.0256     1    0.02556    0.09   0.7653
  Error                                  51.1944   179    0.286                   
  Total                                  52.6636   182                            
Analysis of Variance
Constrained (Type III) sums of squares.
Genotype x Mitochondria Morphology - PSD Area
Table 4: 2x2 Factorial ANOVA output tables for Genotype x Mitochondria 
Morphology. ANOVA results examining ultra tructural features for synapses con-
taining mitochondria: bouton volume (A), spine volume (B), PSD area (C). All sum 






Group Differences in VGLUT2 Particle Size 
To study thalamostriatal axon terminals within the dorsolateral striatum, confocal 
microscopy and immunofluorescent techniques were used to visualize the density and 
distribution of VGLUT2 (Fig. 15, 16) and mHTT (Fig. 18), with the addition of 
colocalization studies to understand where VGLUT2 is colocalized with mHTT (Fig. 19). 
These studies were performed on three wildtype and three Q175+/- animals. For each 
animal, tissue sections were chosen at three levels of the striatum: rostral, middle, and 
caudal. The distribution of VGLUT2+ particles can be seen at all three levels for wildtype 
(Fig. 15) and Q175+/- mice (Fig. 16). For each tissue, particle analysis was done. An overall 
examination of binned frequency distribution of VGLUT2+ immunolabeled particles in 
wildtype and Q175+/- mice reveals significant between-species differences in bin 1 
(wildtype: 15.64 ± 0.15 µm2, Q175+/-: 17.01 ±  0.08 µm2; p = 3.41 x 10-22; Fig. 17). 
Comparison of the cumulative frequency between wildtype and Q175+/- VGLUT2+ 
particle size shows a significant leftward shift in the cumulative distribution of Q175+/- 
VGLUT2+ particles relative to wildtype VGLUT2+ particles (Kolmogorov-Smirnov test, 








Figure 15: Wildtype striatal neuropil immunostained for VGLUT2. Wildtype 
sections at the rostral (A), middle (B), and caudal (C) levels of the dorsolateral 
striatum immunolabelled for VGLUT2 (green). Scale bar: 50 microns  
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Figure 16: Q175 striatal neuropil immunostained for VGLUT2. Q175 sections 
at the rostral (A), middle (B), and caudal (C) levels of the dorsolateral striatum im-
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Figure 17: Distribution of VGLUT2+ particle size. Relative frequency (main) and 
cumulative distribution (upper right) based on binned measurements of VGLUT2+ 




Regional Differences in VGLUT2, mHTT & Colocalized Particle Density 
 To investigate whether there are regional differences in the distribution of VGLUT 
and mHTT in the dorsolateral striatum, particle analysis was performed at rostral, middle, 
and caudal level of the striatum to determine the fractional area occupied by VGLUT2+ 
and mHTT+ particles, as well as dual labelled VGLUT2+/mHTT+ particles. When all 
VGLUT2+ particles were compared, no significant differences in density were observed 
between wildtype and Q175+/- sections. Looking closer at the regional distribution of 
VGLUT2 in the dorsolateral striatum, comparisons between wildtype and Q175+/- 
VGLUT2+ particle density show that there are significant between-species difference at 
the rostral (wildtype: 36.92 ± 2.16 µm2, Q175+/-: 25.20 ± 0.55 µm2; p = 0.001) and middle 
(wildtype: 11.93 ± 0.38 µm2, Q175+/-: 15.17 ± 0.24 µm2; p = 0.025) levels of the 
dorsolateral striatum (Fig. 20A). There were no between-group differences of VGLUT2+ 
density at the caudal level (wildtype: 13.64 ± 0.43 µm2, Q175+/-: 16.30 ± 0.33 µm2). 
Comparison of VGLUT2+ density between the rostral and middle levels revealed 
significant within-species differences (wildtype: p = 7.39 x 10-5; Q175+/-: p = 2.40 x 10-5). 
Comparisons between the rostral and caudal also revealed significant within-species 
differences (wildtype: p = 9.73 x 10-5; Q175+/-: p = 1.32 x 10-4). However, no within-group 
differences of VGLUT2+ density were observed between the middle and caudal levels for 
either group (wildtype and Q175+/-: p > 0.05). Collectively, the variability in VGLUT2+ 
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density in wildtype and Q175+/- along the rostral-caudal axis of the dorsolateral striatum 
suggests that in the normal rodent striatum, VGLUT2 is disproportionately distributed 
rostrally where there is a higher density.  
Comparisons of mHTT+ particle density within Q175+/- tissue sections (Fig. 20) 
also demonstrate inter-areal differences in mHTT+ particle density along the rostral-caudal 
axis of the striatum (Fig. 20B), with the smallest average particle density rostrally (2.54 ± 
0.04 µm2), larger density in middle sections (3.68 ± 0.11 µm2) and highest density caudally 
(5.98 ± 0.91 µm2). A significant areal difference in mHTT+ density was only seen when 
comparing the rostral and middle levels of the striatum (p = 0.003). All other areal 
comparisons were non-significant (rostral and caudal: p > 0.05; middle and caudal: p > 
0.05). Particles positively labelled for both VGLUT2 and mHTT underwent colocalization 
analysis (Fig. 19). Areal comparisons of VGLUT2+ / mHTT+ particle density suggest that 
observed regional differences in dual labeled particle density are not significantly different 
(all p > 0.05) in the dorsolateral striatum (Fig. 20C). 
Figure 18: Q175 striatal neuropil immunostained for mHTT. Q175 sections at 
the rostral (A), middle (B), and caudal (C) levels of the dorsolateral striatum immu-








Figure 19: Q175 striatal neuropil immunostained for VGLUT2 & mHTT. Q175 
sections at the rostral (A), middle (B), and caudal (C) levels of the dorsolateral stri-
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Figure 20: Density of VGLUT2, mHTT, & VGLUT2 / mHTT colocalized parti-
cles. Fractional area of VGLUT2+ (A), mHTT+ (B), and VGLUT2+ / mHTT+ (C) 
particles along the rostral-caudal axis of the dorsolateral striatum. * p < 0.05; ** p 





















 From the earliest studies of the HD brain, the progressive thinning of the striatum 
and cerebral cortex are prominent pathological events of disease progression (Vonsattel & 
DiFiglia, 1998). Atrophy in these regions have consequences on a neuronal and a circuit 
level due the loss of neurons within the respective brain regions. The degeneration of MSNs 
in the striatum leads to alterations in glutamate neurotransmission and may underlie early 
motor abnormalities such as chorea in symptomatic HD individuals (NINDS, 1998). These 
observations and their detrimental consequences highlight the need to understand how the 
presence of mHTT may affect the structure of the synaptic circuitry in the dorsolateral 
striatum at multiple levels. At the ultrastructural level, our data recapitulates differences in 
pre-synaptic and post-synaptic features seen among VGLUT2+ axospinous synapses 
(Deng et al., 2013; Deng et al., 2014) and thalamostriatal input loss to the dorsal striatum 
(Deng et al., 2013; Deng et al., 2014; Parievsky et al., 2017), and further characterizes 
general synapse characteristics and thalamostriatal input loss to the dorsal striatum. An in-
depth examination of the influence of genotype, the presence or absence of VGLUT2, and 
mitochondria morphology as distinct categorical variables demonstrates the multivariate 
relationships between each variable and ultrastructural feature. At the microcircuit level, 
our data provides novel insights into the size, density and distribution of VGLUT2+ and 
mHTT+ immunolabelled particles along the rostral-caudal axis of the dorsolateral striatum. 
Collectively, the findings from this study offer insights into how the presence of mHTT 
impair synaptic transmission at the neuronal and circuit level. 
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 General characteristics of VGLUT2+ and VGLUT2- synapses in Q175+/- animals 
demonstrate an uneven ratio of macular to perforated synapses in Q175+/- animals, with 
79% of VGLUT2+ synapses and 63% of VGLUT2- synapses being macular. In wildtype 
mice, the ratio of macular to perforated synapses is lower, with 59% of VGLUT2+ 
synapses and 54% of VGLUT2- synapses being macular. The disproportionately higher 
ratio of macular to perforated synapses seen among Q175+/- mice in both VGLUT2+ and 
VGLUT2- synapses suggests a shift away from long term potentiation (LTP) of glutamate 
at the synapse, since LTP is positively associated with axospinous synapses that have more 
perforated PSDs, and more perforated axospinous synapses in general (Dhanrajan et al., 
2004; Geinisman, deToledo-Morrell, & Morrell, 1991; Geinisman et al., 1993). From this 
observation, we would expect to find fewer multi-synaptic boutons (MSBs) within Q175+/- 
synapses. However, the number of MSBs remained the same, making up 20-25% of all 
pre-synaptic boutons across wildtype and Q175+/- synapses.  
Quantitative assessments of synapse size were performed on two pre-synaptic 
features and two post-synaptic features. Assessments of pre-synaptic bouton volume reveal 
no significant differences between wildtype and Q175+/- for both VGLUT2+ and 
VGLUT2- axospinous synapses. Our findings follow a similar trend observed by similar 
pre-synaptic cross-sectional measurements of terminal diameter and terminal area among 
VGLUT2+ wildtype and Q140 axospinous synapses (Deng et al., 2013; Deng et al., 2014). 
However, a similar study in age matched R6/2 mice displayed a significant decrease in 
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VGLUT2+ axospinous synapses with D1R- expressing dendritic spines (Parievsky et al., 
2017). Among all VGLUT2+ synapses, mitochondria present in Q175+/- pre-synaptic 
boutons demonstrate a significant lower volume compared to wildtype. Examination of 
morphology reveals a ~3:1 ratio of damaged to normal mitochondria, as 65% of VGLUT2+ 
synapses and 71% of VGLUT2- synapses contained damaged mitochondria. Within these 
mitochondria, evidence of mitochondrial fission and abnormal elongation was found in 
Q175+/- mice, consistent with observations from previous HD studies (Costa et al., 2010; 
Song et al., 2011). Wildtype and Q175+/- VGLUT2- pre-synaptic features were comparable 
but non-significant. 
Comparisons of post-synaptic spine volume and the area occupied by the PSD at 
the synaptic junction (PSD area) both demonstrated significant differences between 
wildtype and Q175+/- VGLUT2+ synapses. Notably, the average spine volume in wildtype 
animals was approximately two times larger than the average Q175+/- spine, contrasting to 
spine volume measurements from in wildtype and Q175+/- VGLUT2- synapses which were 
relatively similar. The cumulative distribution of spine volumes in VGLUT2+ synapses 
reveal a significant leftward shift, indicating that a higher frequency of smaller spines was 
seen in Q175+/- neuropil. Reductions in spine size have also been observed among 
thalamostriatal axospinous synapses with D1R- and D2R- labelled spines in Q140 mice, 
but only D1R- spines showed a significant decrease in cross-sectional spine area relative 
to wildtype (Deng et al., 2014). The average PSD area was also significantly different 
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among VGLUT2+ synapses, with reductions observed among Q175+/- synapses relative to 
wildtype. No significant differences were seen between wildtype and Q175+/- mice for any 
VGLUT2- synaptic features. The density of Q175+/- VGLUT2+ synapses among all 3D 
reconstructed synapses was reduced two-fold compared to wildtype synapses. This was 
observed among Q175+/- VGLUT2- synapses as well. Separate correlation analyses among 
pre- and post-synaptic features of wildtype and Q175+/- synapses show that the only 
significant correlations were observed between PSD area and post-synaptic spine volume 
in VGLUT2+ and VGLUT2- wildtype synapses, suggesting that pre- and post-synaptic 
ultrastructural features may not be linearly or causally related in Q175+/- VGLUT2+ and 
VGLUT2- axospinous synapses.     
To understand the specific influence of genotype and synaptic input (presence or 
absence of VGLUT2) categorical type on synaptic and mitochondrial ultrastructural 
features (volume and damage), we used multivariate comparisons of our outcome 
measures. When comparisons were made for ultrastructural features from all synapses, 
genotype was not a significant main effect for any features. However, after excluding the 
features from synapses without mitochondria, genotype was a significant main effect for 
pre-synaptic bouton volume, pre-synaptic mitochondria volume and post-synaptic spine 
volume. Comparisons of genotype and mitochondria morphology (normal or abnormal) 
categorical types on ultrastructural features from the same group of synapses reveals that 
genotype was a significant main effect for pre-synaptic bouton volume, post-synaptic spine 
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volume and PSD area. These results suggest that the presence of mHTT (genotype) is a 
reliable predictor of pre- and post-synaptic ultrastructural features the presence of mHTT 
(genotype) coupled with observations of mitochondria morphology may be a better 
predictor of observed reductions in the area of synapse of the PSD at the synaptic junction 
among axospinous synapses containing mitochondria. Further studies are needed to 
determine the significant interactions between the categorical variables in these 
comparisons. 
Considering our analyses examining the relationships between numerous 
categorical variables and the observations of reduced mitochondria size and aberrant 
morphology, our results suggests that the mHTT may be altering the synaptic properties 
observed among thalamostriatal axospinous synapses in a cell autonomous manner by 
affecting normal mitochondria function. However, further characterization of mHTT 
proteins at the ultrastructural level is required to determine this causal relationship. The 
comparisons described above may also explain why a linear relationship between pre-
synaptic bouton volume and PSD area was only observed among wildtype synapses, but 
not for Q175+/- synapses. Together our results corroborate and support the notion that 
differences observed between wildtype and Q175+/- axospinous synapses may be non-
linearly influenced by levels of various synaptic categorical variables.  
Confocal studies of the dorsolateral striatum demonstrate that there are no significant losses 
to thalamostriatal inputs to the dorsolateral striatum between wildtype and Q175+/- mice at 
12-months, corroborating a previous study from our lab. However, in-depth analyses of 
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VGLUT2 distribution suggests that VGLUT2 is not uniform along the rostral-caudal axis 
of the dorsolateral striatum. This observation was seen among both wildtype and Q175+/- 
mice. VGLUT2 was disproportionately distributed rostrally where there was a higher 
density, while a lower density was found caudally. The cumulative distribution of 
VGLUT2+ particle size reveals a significant leftward shift, indicating that a higher 
frequency of smaller particles was seen among Q175+/- synapses. Both between-group and 
regional comparisons of VGLUT2 density distribution demonstrates that the presence of a 
topographical distribution of VGLUT2 along the rostral-caudal axis. Within-group 
comparisons for Q175+/- sections demonstrates that the distribution of mHTT is inversed, 
as there was a lower density of mHTT rostrally and a higher density caudally. This 
observation remained true for particles double labelled for VGLUT2 and mHTT.  
Observations from our confocal studies support the pattern of early motor deficits 
observed among symptomatic HD individuals (NINDS, 1998). Functional distinctions 
along the rostral-caudal axis suggest that the rostral end of the dorsal striatum receives 
glutamatergic projections from the frontal and parietal cortical areas, while the caudal 
receives projections from the primary motor and somatosensory cortices (Ferré et al., 
2018). Within the thalamus, one study found that input from thalamic intralaminar nuclei 
in the parafascicular (parafascicular, posterior, and centrolateral nuclei) and the 
ventroposterior (ventroposteromedial, ventromedial, and ventroposterolateral nuclei) 
regions of the thalamus are the main inputs to the dorsomedial and dorsolateral striatum 
respectively and that these thalamostriatal projections contribute to the smooth initiation 
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of movement, with ventroposterior nuclei specifically influencing the motor execution of 
learned motor actions (Díaz-Hernández et al., 2018). Though this study doesn’t specify the 
regional contributions of these projections along the rostral-caudal axis in the striatum, 
studies of the MSNs projecting to the caudal rodent striatum suggest that the caudal regions 
of the cerebral cortex and the thalamus as the main projections to the caudal striatum (Jiang 
& Kim, 2018). Collectively, these findings suggest that glutamatergic projections from 
ventral motor thalamic nuclei and caudal intralaminar nuclei from the centromedian-
parafascicular nuclear complex are the main contributors of thalamic motor input to the 
caudal level of the dorsal striatum. Our confocal studies, which suggest a significant 
reduction in VGLUT2+ axon terminals at the caudal level of the dorsolateral striatum 
supports these anatomical distinctions and is in line with observed motor deficits at the 
symptomatic stage of HD. 
 The results of this study demonstrate that the presence of mHTT may be altering 
the synaptic circuitry at the ultrastructural and microcircuit levels in the Q175+/- model 
mice. At the ultrastructural level, the findings of our study recapitulate observations of the 
influence that mHTT may have on pre- and post-synaptic elements of VGLUT2+ 
axospinous synapses (Deng et al., 2013; Deng et al., 2014; Parievsky et al., 2017). Pre-
synaptically, we observed a preservation of axon terminal size, but reductions in 
mitochondria size and aberrant mitochondria morphology in pre-synaptic boutons. We also 
observed a two-fold reduction in post-synaptic spine volume, in addition to reduced 
synapse area at the synaptic junction. Overall, a 50% reduction in thalamostriatal 
axospinous synapse abundance was observed. There were marked differences in our results 
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when compared to previous ultrastructural studies (Deng et al., 2013; Deng et al., 2014; 
Parievsky et al., 2017). The most likely explanation for the observed differences is the 
specific mouse model used in each study, as the Q140 and R6/2 models contain 140 and 
144 polyQ repeats respectively (Mangiarini et al., 1996; Menalled et al., 2012), while the 
Q175+/- model used in the current study contains 188 polyQ repeats (Menalled et al., 2012). 
Interestingly enough, considering the inverse relationship with length of polyQ repeats 
leads to earlier disease severity (HDCRG, 1993), we expected to find a greater loss of 
thalamostriatal terminals at 12-months. This was not the case as only a 50% reduction was 
observed. These differences can be attributed to numerous factors such as methodology, 
experimental design, and counting methods. For example, the referenced ultrastructural 
studies utilized 2D methods as pre- and post-synaptic measurements were derived from 
cross sectional area (Deng et al., 2013; Deng et al., 2014; Parievsky et al., 2017) while our 
measurements were derived from volumetric features from 3D reconstructed synaptic 
elements. Additionally, the R6/2 study did not use stereological methods in their 
quantification of synapse density so their results may be an underestimation of synapse loss 
in the dorsolateral striatum (Parievsky et al., 2017). Despite these differences, our results 
are in general agreement with the idea that the presence of mHTT has a larger impact on 
post-synaptic elements of VGLUT2+ axospinous synapses than pre-synaptic elements in 
the brains of symptomatic HD mouse models. 
 In the current study, D1- and D2- expressing MSNs were not labelled – both our 
ultrastructural and confocal microscopy studies identified VGLU2+ labelled axon 
terminals. Studies of VGLUT1+ and VGLUT2+ excitatory glutamatergic terminals at the 
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microcircuit level found that all axon terminals were located within 1 µm of a dopaminergic 
synapse, suggesting that MSNs synapses receiving excitatory afferents share the same 
structural relationships as MSNs modulated by DA (Moss & Bolam, 2008). Applying this 
relationship, our findings of a rostral-to-caudal reduction in VGLUT2 density suggests that 
a similar observation among VGLUT2 axon terminals synapsing onto D1- and D2- 
expressing spines might be observed. However, human imaging studies and a rodent study 
using immunohistochemical methods examining the distribution of D1- and D2- receptor 
in the dorsal striatum found that the density of D1- receptor expression along the rostral-
caudal axis was decreased in the putamen while not in the caudate nuclei, but D2- receptor 
expression increasing along the rostral-caudal axis for both nuclei (Piggott et al., 1999). 
The rodent study found that D2- receptor expression along the same axis was decreased in 
the caudate nuclei, contrasting to the previous study (Levey et al., 1993). Previously, our 
lab described significant functional changes in D1- receptor expressing MSNs and not D2- 
MSNs in the Q175+/- HD model (Goodliffe et al., 2018). The distribution of D1- and D2- 
MSNs along the rostral-caudal axis has not been extensively studied. However, one study 
found that D2 receptor expression was lower in a specific caudal region of the mouse 
striatum where a high expression of D1 receptors were found, but otherwise found that the 
distribution of D1 and D2 receptor expression was random in the dorsal striatum 
(Gangarossa et al., 2013). Further studies are needed to determine if there are regional 
differences in D1- and D2- receptor expression along the rostral-caudal axis and whether 
the differences support distinct functions of the specific thalamostriatal inputs at each level. 
Only then can a pathway- and region-specific relationship be formulated. 
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The current study of thalamostriatal afferents to the striatum only tells half of the 
story of the effect that mHTT presence may have on glutamate neurotransmission. The 
other half of the story involves excitatory corticostriatal afferents. Further studies of 
corticostriatal input loss and characterization of VGLUT1+ axospinous synapses in 
symptomatic HD mice (12-months) at the ultrastructural level will provide insight to the 
global excitatory: inhibitory imbalance occurring along the rostral-caudal axis of the 
dorsolateral striatum. However, the results of this study demonstrate a 50% reduction in 
VGLUT2+ axospinous synapses in Q175+/- animals at an ultrastructural level. At the 
microcircuit level, a significant 32% reduction (overall 9.7% reduction) of VGLUT2+ 
spatial abundance within rostral regions of the dorsolateral striatum. It is important to 
remember that the results from our confocal studies do not differentiate between 
axospinous and axodendritic axon terminals. However, studying the synaptic alterations at 
both levels suggest that the presence of mHTT may contribute to both cell-autonomous 
mechanisms as seen on the ultrastructural level, and possibly non-cell autonomous 
mechanisms that may affect the larger local striatal synaptic circuit. A loss of excitatory 
glutamatergic inputs to the striatum continue to further corroborates the idea that an 
excitatory: inhibitory imbalance may contribute to structural synaptic changes. However, 
further studies are needed to determine the way that these mechanisms may affect synaptic 
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